These data indicate that salivary MMP-1 levels can be used to effectively discriminate OSCCs occurring at the oral cavity including cheek mucosa, gum, tongue (excluding base of tongue), and multiple sites at the oral cavity from non-cancerous groups (HC and OPMD). Here, MMP1 is linked to oculopharyngeal muscular dystrophy.